Previous reports on the involvement of FGF-21 in the pathogenesis and potential treatment of ROP primarily derive from preclinical models. tPA, a crucial component of the fibrinolytic system, showed the second most pronounced effect size for severe ROP, also rising faster in the first postnatal days. The gene discussed is PLAT; the disease is retinopathy of prematurity.